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ABSTRACT
OBJECTIVE: To estimate factors associated to illicit drug use among patients with mental illness 
in Brazil according to gender. 
METHODS: A cross-sectional representative sample of psychiatric patients (2,475 individuals) 
was randomly selected from 11 hospitals and 15 public mental health outpatient clinics. Data 
on self-reported illicit drug use and sociodemographic, clinical and behavioral characteristics 
were obtained from face-to-face interviews. Logistic regression was used to estimate associations 
with recent illicit drug use. 
RESULTS: The prevalence of any recent illicit drug use was 11.4%. Men had higher prevalence 
than women for all substances (17.5% and 5.6%, respectively). Lower education, history of 
physical violence, and history of homelessness were associated with drug use among men only; 
not professing a religion was associated with drug use in women only. For both men and women, 
younger age, current hospitalization, alcohol and tobacco use, history of incarceration, younger 
age at sexual debut, and more than one sexual partner were statistically associated with illicit 
drug use. 
CONCLUSIONS: Recent illicit drug use among psychiatric patients is higher than among 
the general Brazilian population and it is associated with multiple factors including markers of 
psychiatric severity. Our data indicate the need for the development of gender-based drug-use 
interventions among psychiatric patients in Brazil. Integration of substance use treatment 
strategies with mental health treatment should be a priority. 
DESCRIPTORS: Mentally Ill Persons. Street Drugs. Risk Factors. Gender and Health. Multicenter Study.
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INTRODUCTION
Illicit drug abuse and dependence are important public health issues worldwide. Data 
from the World Health Organization (WHO) show that substance use and mental 
disorders are, together, the number one cause of years lost due to disability (22% of YLD) 
and the 15 highest cause of disability-adjusted life years (7.4% of DALYs)32. During 2010, 
3.4% to 6.6% of the worldwide adult population used some illicit substance, and 10% 
to 13% of this population demonstrated abuse or dependence. Illicit drug use greatly 
increases the probability of having health risk behavior and is associated with higher 
rates of overdose, suicide, violence, HIV infection, and sexual risk behavior26,30. Injecting 
drugs further increases these risks, and needle sharing may transmit blood-borne 
diseases among users30. 
The association between mental disorders and psychoactive substance use has been 
frequently discussed in the literature since the 1990s. Despite varying prevalence rates 
in different countries22, high prevalence of illicit drug use in psychiatric patients is 
evident2,14,18,23. Data from the USA indicate that, while 3.7% of the persons without history 
of mental illness had a history of lifetime drug abuse or dependence, the rate was 14.7% 
(OR = 4.7; 95%CI 3.5–6.3) among those with any lifetime mental illness diagnosis23. 
In the United Kingdom, Fisher et al.6 identified that psychiatric patients had twice the 
chance of developing a substance use disorder as compared to those with no mental 
disorders. A study carried out in São Paulo, Brazil, showed that 4.7% of adult patients 
with severe mental illness (SMI) in treatment fulfilled criteria for abuse or dependence 
of illicit drug use and 8.3% had used an illicit substance in the past year19. A current 
comorbid substance use disorder was present in 11.2% of a sample of outpatients with 
SMI in Rio de Janeiro, Brazil31. 
Illicit drug use is associated with multiple factors, including child sexual abuse, parental 
violence, parents or sibling who also use drugs, and being younger, male, single, and with 
lower schooling3,5. Similar to the general population, drug use among patients with mental 
illness is higher among those who are male, younger3,11,12,18, single18, have family members 
who use drugs3, or have a history of homelessness or incarceration23. 
There is a remarkable difference in rates of drug use between men and women. Use among 
women is lower than among men, with differences that vary from a 3:4 ratio in the United 
States to 1:10 in India and Indonesia30, indicating higher vulnerability among men. The 
only instance in which this ratio is reversed is in the use of tranquilizers and sedatives. 
Comorbidity between severe mental illness and substance use disorders is more prevalent 
among men, whereas women with alcohol or drug-associated disorders had twice the risk 
of having depressive and anxiety disorders when compared to men29. 
Illicit drug use and mental illness can have a negative impact on health such as reduced 
adherence to treatment and worsen prognosis, leading to more intensive and expensive 
treatments in emergency settings2,6. However, few surveys on the association between illicit 
drug use and mental illness have been conducted in low and middle-income countries11. 
Brazil has scarce published data on illicit drug use among patients with mental illness and 
no studies with a national representative sample. This study aimed to estimate the risk 
behavior factors associated with recent illicit drug use among patients with mental illness 
in Brazil according to gender. 
METHODS 
We obtained data from a large national multicenter cross-sectional study conducted in 
2006. The main objective was to determine the prevalence of infection with HIV, syphilis, 
and hepatitis B and C in a sample of adult psychiatric patients (18 years of age or older) 
in treatment in Brazil20. 
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A two-stage sampling procedure was carried out with a random selection of centers in 
each region followed by random selection of participants within each center20. Sample 
size calculation considered 50% average estimate of the conditions, 0.2% precision, 5% 
confidence level, and a potential 40% loss. It was proportional to the type of care (hospital 
or Psychosocial Care Centers [CAPS]) and to the distribution of AIDS cases in the regions. 
Among the 3,255 patients recruited, 2,763 (84.9%) were considered eligible as previously 
described8. From these patients, 288 (10.4%) did not participate for various reasons (such 
as refusal, non-attendance, death), amounting to a 26% loss for the interview, below the 
initial estimate of 40%. Public outpatient mental health clinics that exclusively treated 
substance use disorders (CAPS AD) were excluded from the sampling process to prevent 
the overestimation of the selected risk behaviors or prevalence rates. The study was carried 
out with 2,475 patients recruited from 11 psychiatric hospitals and 15 public mental health 
outpatient clinics (CAPS) distributed in the five Brazilian macroregions. 
Patients who agreed to participate and were considered eligible underwent a face-to-face 
interview with a semi-structured questionnaire, tested in a preliminary pilot study8, to collect 
information about health care, behavioral characteristics, and sociodemographic profile. 
Healthcare professionals who worked at the treatment services administered the interviews. 
Additional clinical data such as psychiatric diagnosis and treatment characteristics were 
collected from the medical records. The study included only patients able to provide written 
informed consent and who were able to answer the questionnaire after the administration 
of a preliminary assessment adapted from the Mini-Mental State Examination (MMSE). 
Further details have been previously published8. 
The outcome of interest for this analysis was recent illicit drug use (i.e., patients that reported 
using any illicit drug at least once during the 12 months prior to the interview). The illicit 
drugs considered were marijuana, cocaine, crack, hallucinogens, amphetamines, opiates, 
solvents, or other non-prescribed or illicit drugs. 
Potential explanatory variables were divided into three groups: sociodemographic, 
clinical characteristics, and risk behavior. Sociodemographic characteristics included 
age, skin color, marital status, schooling, having an income in the last six months, place of 
residence, and professing a religion. Median age (40 years old) was used as a cutoff point. 
Skin color was dichotomized as non-white and white. For marital status, those who were 
single, separated/divorced, or widowed were grouped into one category. The cutoff point 
for schooling was five years ( first cycle of elementary school). For housing, those living 
in houses or apartments were considered stable, while those living in shelters, pensions, 
hostels, and on streets were grouped as unstable. Clinical characteristics included main 
psychiatric diagnosis, history of hospitalization, medical comorbidities, and history 
of sexually transmitted infections (STI). The main psychiatric diagnosis was classified 
according to the International Classification of Diseases (ICD-10), defined by a psychiatrist 
as registered in the medical chart. This variable was dichotomized into severe mental illness 
(SMI) and compared to the other diagnoses. Severe mental illnesses included diagnoses 
of schizophrenia, bipolar disorders, and depression with psychotic symptoms25. History of 
hospitalization was analyzed by dividing the sample into three categories: those who were 
hospitalized in one of the participating psychiatric hospitals during the study; those who 
were under care in CAPS but had a history of any previous hospitalization; and those who 
were under care in CAPS and had never been hospitalized. Risk behavior characteristics 
included the following variables: lifetime tobacco use, lifetime alcohol use, history of 
homelessness, history of physical and sexual violence, history of incarceration, age of 
first sexual intercourse, number of partners, and practice of unprotected sex. Lifetime 
risk behavior self-reports have demonstrated reliability8. The cutoff point for age at first 
sexual intercourse was 18 years. Finally, those with two or more lifetime sexual partners 
were compared to those with only one or no partners, and unprotected sex was defined 
as not always using condoms in all sexual practices (ever). 
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Analyses were conducted separately for men and women. Descriptive analyses were 
carried out and the prevalence of recent illicit drug use was calculated by dividing the 
number of participants who reported using any illicit drug in the 12 months prior to the 
interview by the total number of participants, with 95% confidence interval (95%CI). For 
the univariate analysis, differences in proportion were assessed by Pearson’s Chi-square test, 
and the magnitude of the associations was estimated by the odds ratio (OR) with 95%CI. 
A multivariate logistic model was used to estimate the independent effect of potential 
explanatory variables, using a sequential backward elimination method. Variables that 
presented p < 0.20 in the univariate analysis were initially included. Wald test was used to 
assess the statistical significance of each variable. Only those with p < 0.05 remained in the 
final model. Goodness of fit was assessed by the Hosmer-Lemeshow test. For statistical 
analysis, EpiInfo 7 and Stata 12 were used. 
RESULTS 
All participants who answered to the questionnaire were included in the study (n = 2,475): 
51.6% were women (n = 1,277) and 48.4% were men (n = 1,198). As shown in Table 1, most 
men and women were 40 years old or over, single, with no income in the last six months, 
had stable housing, and professed a religion. Men were more likely than women to be single 
(75.8%) and to live in unstable housing (17.5%), whereas women were more likely than 
men to profess a religion (87.8%). Men were also more likely than women to have a severe 
mental illness diagnosis (61.0%), to be hospitalized during the study period (45.0%), and 
to have a prior history of hospitalization (34.4%). Overall, high prevalence of self-reported 
medical comorbidities (45.3%) and history of STI (23.3%) was also found. In addition, 
men had a higher proportion of tobacco smoking, alcohol drinking, early sexual debut 
(< 18 years old), more than one lifetime sexual partner, and history of incarceration and 
homelessness, whereas women had a higher proportion of history of sexual violence and 
lifetime unprotected sex (Table 1). 
The overall prevalence of any illicit drug use was 11.4% in the past year and 25.4% during 
lifetime (Table 2). Compared to women, men had a higher prevalence of drug use, 17.5% 
versus 5.6% in the past year and 36.8% versus 14.7% for lifetime, respectively. For both men 
and women, the substance used with the highest prevalence was marijuana (8.8% in the 
past year and 21.9% for lifetime), followed by cocaine (3.4%, in the past year and 10.6% for 
lifetime). Both were more prevalent among men than women. A small proportion of the 
sample (2.9%) reported lifetime injection drug use, and use of more than one drug was 
reported by 24.1% of the men and 5.7% of the women. Finally, men had a higher proportion 
of drug use during sex (13.4%) and exchange of money or drugs for sex (40.4%) compared 
to women (5.6% and 13.2%, respectively) (Table 2). 
In the univariate analysis, most of the variables investigated were statistically associated 
(p < 0.05) with recent illicit drug use (Table 3) for both men and women, including being 
younger, having less schooling, previous history of hospitalization, history of STI, and all risk 
behavior characteristics. On the other hand, being single and having an unstable place of 
residence were associated with illicit drug use among men only, and not professing a religion 
and medical comorbidities were associated with women only. 
The final multivariate models (Table 4) indicated that age (< 40 years old), history of 
hospitalization, lifetime tobacco use, lifetime alcohol use, history of incarceration, age 
at sexual debut (< 18 years old), and number of sexual partners (two or more) remained 
independently associated (p < 0.05) with illicit drug use for both genders. In addition, 
not professing a religion also remained statistically significant among women, and lower 
schooling (< 5 years), history of homelessness, and history of physical violence remained 
statistically significant among men in the respective final models. Having an SMI diagnosis 
did not remain significant. 
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Table 1. Sociodemographic, clinical, and risk behavior characteristics by gender. PESSOAS Project, 
2006–2007, Brazil. (n = 2,475) 
Characteristic
Men Women Total
(n = 1,198) (n = 1,277) (n = 2,475)
n %* n %* n %*
Sociodemographic
Age (years old)
< 40 594 49.6 530 41.5 1,124 45.4
≥ 40 604 50.4 747 58.5 1,351 54.6
Skin color
Non-white 613 51.2 587 46.0 1,200 48.5
White 584 48.8 689 54.0 1,273 51.5
Marital status
Single/Separated/Divorced/Widowed 907 75.8 746 58.4 1,653 66.8
Married/Common-law marriage/Other 290 24.2 531 41.6 927 33.2
Schooling (years)
< 5 593 49.5 660 51.7 1,253 50.6
≥ 5 605 50.5 617 48.3 1,222 49.4
Income in last 6 months
Yes 438 40.6 449 35.2 932 37.8
No 708 59.4 825 64.8 1,533 62.2
Housing
Unstable 209 17.5 109 8.6 318 12.9
Stable 987 82.5 1,166 91.5 2,153 87.1
Profess any religion
Yes 935 78.7 1,118 87.8 2,053 83.4
No 253 21.3 155 12.2 408 16.6
Clinical
Main psychiatric diagnosis
SMI 731 61.0 682 53.4 1,413 57.1
Non-SMI 467 39.0 595 46.6 1,062 42.9
Psychiatric hospitalization
Current 537 44.9 361 28.3 898 36.4
Prior 411 34.4 378 29.7 789 31.9
Never admitted 247 20.7 535 42.0 782 31.7
Self-reported medical comorbidity
Yes 483 40.8 626 49.4 1,109 45.3
No 700 59.2 641 50.6 1,341 54.7
History of STI
Yes 311 26.4 257 20.4 568 23.3
No 869 73.6 1,003 79.6 1,872 76.7
Risk behavior
Tobacco use (ever)
Yes 970 81.3 798 62.9 1,768 71.8
No 223 18.7 470 37.1 693 28.2
Alcohol use (ever)
Yes 924 77.5 667 52.7 1,591 64.7
No 269 22.5 598 47.3 867 35.3
History of homelessness
Yes 255 21.5 189 15.0 444 18.1
No 934 78.5 1,071 85.0 2,005 81.9
Physical violence
Yes 695 58.2 736 57.9 1,431 58.0
No 499 41.8 536 42.1 1,035 42.0
Continue
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Table 1. Sociodemographic, clinical, and risk behavior characteristics by gender. PESSOAS Project, 
2006–2007, Brazil. (n = 2,475). Continuation
Sexual violence
Yes 150 12.6 339 26.8 489 19.9
No 1,040 87.4 928 73.2 1,968 80.1
History of incarceration
Yes 493 41.3 135 10.6 628 25.5
No 701 58.7 1,135 89.4 1,836 74.5
Age of first sexual intercourse
< 18 years old 632 65 561 50.6 1,193 57.3
≥ 18 years old 341 35 548 49.4 889 42.7
Number of sexual partners
One or never had sex 292 26 513 42.6 805 34.6
Two or more 832 74 691 57.4 1,523 65.4
Unprotected sex
Yes 909 76.8 1,055 83.5 1,964 80.2
No 275 23.2 209 16.5 484 19.8
SMI: Severe mental illness
* Total values vary because of missing observations.
Table 2. Descriptive characteristics of illicit drug use (recent and lifetime) by gender. PESSOAS Project, 
2006–2007, Brazil. (n = 2,475) 
Characteristic
Men Women Total
(n = 1,198) (n = 1,277) (n = 2,475)
n %* n %* n %*
Use in the past year
Marijuana 170 14.2 47 3.7 217 8.8
Cocaine 67 5.6 18 1.4 85 3.4
Solvents 47 3.9 12 0.9 59 2.4
Crack 105 8.8 28 2.2 133 5.4
Hallucinogens 18 1.5 3 0.2 21 0.9
Amphetamine 21 1.8 19 1.5 40 1.6
Opiates 7 0.6 2 0.2 9 0.4
Any illicit drug 210 17.5 71 5.6 281 11.4
Lifetime use
Marijuana 403 33.6 138 10.8 541 21.9
Cocaine 205 17.1 57 4.5 262 10.6
Solvents 198 16.5 46 3.6 244 9.9
Crack 164 13.7 48 3.8 212 8.6
Hallucinogens 86 7.2 20 1.6 106 4.3
Amphetamine 60 5.0 44 3.5 104 4.2
Opiates 22 1.8 7 0.6 29 1.2
Any illicit drug 441 36.8 188 14.7 629 25.4
Drug use (lifetime)
None 752 64.1 1,083 85.6 1,835 75.2
One drug only 138 11.8 111 8.8 249 10.2
Two or more drugs 283 24.1 72 5.7 355 14.6
Injection drug use (lifetime)
Yes 53 4.5 19 1.5 72 2.9
No 1,134 95.5 1,246 98.5 2,380 97.1
Drug use during sexual practices
Yes 132 13.4 60 5.6 192 9.3
No 853 86.6 1,017 94.4 1,870 90.7
Exchange money/drugs for sex
Yes 484 40.4 168 13.2 652 26.3
No 714 59.6 1,109 86.8 1,823 73.7
* Total values vary because of missing observations. 
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Table 3. Univariate analysis of recent illicit drug use stratified by gender. PESSOAS Project, 2006–2007, Brazil. (n = 2,475)
Characteristic Total*
Men (n = 1,198)
Total*
Women (n = 1 ,277)
Drug use
OR 95%CI p
Drug use
OR 95%CI p
n % n %
Sociodemographic
Age (years old)
< 40 594 168 28.3 5.28 3.68–7.57 0.000 530 45 8.5 2.57 1.56–4.23 0.000
≥ 40 604 42 6.9 1.00 747 26 3.5 1.00
Skin color
Non-white 613 108 17.6 1.01 0.75–1.36 0.945 587 38 6.5 1.37 0.85–2.22 0.190
White 584 102 17.5 1.00 689 33 4.8 1.00
Marital status
Single/Separated/Divorced/Widowed 907 181 20.0 2.24 1.48–3.40 0.000 746 47 6.3 1.42 0.86–2.35 0.171
Married/Common-law marriage/Other 290 29 10.0 1.00 531 24 4.5 1.00
Schooling (years)
< 5 593 146 24.6 2.76 2.00–3.80 0.000 660 45 6.8 1.66 1.01–2.73 0.042
≥ 5 605 64 10.6 1.00 617 26 4.2 1.00
Income in last 6 months
Yes 483 85 17.6 0.99 0.74–1.35 0.979 449 28 6.2 1.21 0.74–1.98 0.446
No 708 125 17.7 1.00 825 43 5.2
Housing
Unstable 209 24 11.5 0.56 0.35–0.88 0.011 109 6 5.5 1.00 0.42–2.38 0.994
Stable 987 186 18.8 1.00 1,166 64 5.5 1.00
Profess any religion
Yes 935 167 17.9 1.00 1,118 55 4.9 1.00
No 253 43 17.0 0.94 0.65–1.36 0.749 155 16 10.3 2.22 1.24–3.99 0.006
Clinical
Main psychiatric diagnosis
SMI 731 125 17.1 0.93 0.68–1.26 0.641 682 41 6.0 1.20 0.74–1.96 0.450
Non-SMI 467 85 18.2 1.00 595 30 5.0 1.00
Psychiatric hospitalization
Current 537 145 27.0 3.98 2.45–6.47 0.000 361 41 11.3 6.10 3.09–12.05 0.000
Prior 411 44 10.7 1.29 0.75–2.23 0.360 378 19 5.0 2.52 1.19–5.36 0.016
Never admitted 247 21 8.5 1.00 535 11 2.1 1.00
Self-reported medical comorbidity
Yes 483 89 18.4 1.09 0.80–1.48 0.587 626 27 4.3 0.61 0.37–1.00 0.048
No 700 120 17.4 1.00 641 44 6.9 1.00
History of STI
Yes 311 76 24.4 1.77 1.29–2.44 0.000 257 23 8.9 1.96 1.17–3.28 0.009
No 869 134 15.4 1.00 1,003 48 4.8 1.00
Risk behavior
Tobacco use (ever)
Yes 970 210 17.6 6.22 3.13–12.33 0.000 798 63 7.9 4.95 2.35–10.42 0.000
No 223 9 4.0 1.00 470 8 1.7 1.00
Alcohol use (ever)
Yes 924 197 21.3 5.34 2.99–9.52 0.000 667 58 8.7 4.29 2.32–7.90 0.000
No 269 13 4.83 1.00 598 13 2.2 1.00
History of homelessness
Yes 255 78 30.6 2.72 1.97–3.77 0.000 189 24 12.7 3.17 1.89–5.32 0.000
No 934 130 13.9 1.00 1,071 47 4.4 1.00
Physical violence
Yes 695 166 23.9 3.33 2.33–4.76 0.000 736 56 7.6 3.07 1.69–5.58 0.000
No 499 43 8.6 1.00 536 14 2.6 1.00
Continue
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Table 3. Univariate analysis of recent illicit drug use stratified by gender. PESSOAS Project, 2006–2007, Brazil. (n = 2,475). Continuation
Sexual violence
Yes 150 38 25.3 1.74 1.16–2.59 0.000 339 34 10.0 2.9 1.79–4.80 0.000
No 1,040 170 16.4 1.00 928 34 3.7 1.00
History of incarceration
Yes 493 136 27.6 3.33 2.43–4.55 0.000 135 23 17.0 4.75 2.78–8.12 0.000
No 701 72 10.3 1.00 1,135 47 4.1 1.00
Age of first sexual intercourse
< 18 years old 632 156 24.7 2.27 1.57–3.28 0.000 561 55 9.8 4.15 2.28–7.55 0.000
≥ 18 years old 341 43 12.6 1.00 548 14 2.6
Number of sexual partners
Only one or never had sex 292 12 4.1 1.00 513 5 1.0 1.00
Two or more 832 188 22.6 6.81 3.73–12.41 0.000 691 63 9.1 10.19 4.07–25.53 0.000
Unprotected sex
Yes 909 183 20.1 2.63 1.68–4.13 0.000 1,055 66 6.3 4.58 1.43–14.72 0.005
No 275 24 8.7 1.00 209 3 1.4 1.00
SMI: Severe mental illness
* Total values vary because of missing observations.
Table 4. Multivariate analysis stratified by gender. PESSOAS Project, 2006–2007, Brazil. (n = 2,358) 
Characteristic
Men (n = 1,146) Women (n = 1,212)
OR 95%CI p OR 95%CI p
Sociodemographic
Age (years old)
< 40 6.12 4.06–9.26 0.000 1.87 1.06–3.30 0.030
≥ 40 1.00 1.00
Schooling (years)
< 5 2.72 1.84–4.02 0.000 - - -
≥ 5 1.00 - - -
Profess a religion
Yes - - - 1.00
No - - - 2.09 1.07–4.08 0.032
Clinical
Psychiatric hospitalization
Current 2.37 1.36–4.13 0.002 4.46 2.13–9.31 0.000
Prior 0.93 0.50–1.72 0.818 1.96 0.88–4.36 0.097
Never admitted 1.00 1.00
Risk behavior
Tobacco use (ever)
Yes 5.57 2.64–11.75 0.000 2.47 1.12–5.42 0.025
No 1.00 1.00
Alcohol use (ever)
Yes 2.35 1.22–4.54 0.011 2.17 1.12–4.22 0.022
No 1.00 1.00
History of homelessness
Yes 1.75 1.17–2.63 0.007 - - -
No 1.00 - - -
Physical violence
Yes 1.78 1.16–2.73 0.008 - - -
No 1.00 - - -
History of incarceration
Yes 2.49 1.78–3.5 0.000 1.98 1.07–3.65 0.029
No 1.00 1.00
Age of first sexual intercourse
< 18 years old 1.66 1.07–2.58 0.023 2.39 1.23–4.63 0.010
≥ 18 years old 1.00 1.00
Number of sexual partners
One or never had sex 1.00 1.00
Two or more 3.26 1.55–6.86 0.002 4.32 1.58–11.83 0.004
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DISCUSSION 
Our study found higher rates of both past year (11.4%) and lifetime (25.4%) illicit drug use 
among psychiatric patients in relation to the rates in the Brazilian general population 
according to a household survey on drug use carried out in a similar period (2005) 
in collaboration with the Brazilian National Department on Drug Policies1. Moreover, 
we found higher proportions of specific drug use compared with the same study1 in the past 
year (8.8% and 2.6% for marijuana, 3.4% and 0.7% for cocaine, 2.4% and 1.2% for solvents, 
5.4% and 0.1% for crack use, respectively) and lifetime (21.9% and 8.8% for marijuana, 10.6% 
and 2.9% for cocaine, 9.9% and 6.1% for solvents, 8.6% and 0.7% for crack use, respectively). 
Higher proportions of illicit drug consumption among psychiatric patients are also found 
in other countries when compared to the general population, with similar results2,6,14,18,23.. 
In a study carried out in London, Menezes et al.18 found that 43.3% of patients with SMI 
had used any drug during lifetime, and 4.7% of them presented some degree of substance 
use disorder in the year prior to the study. A review of the published literature on drug use 
among psychotic patients in the United Kingdom2 showed prevalence rates varying from 
15% to 45% in the past year and from 16% to 68% for lifetime use. 
In this study, for all substances, men had higher prevalence of use than women in the past 
year (marijuana: 14.2% versus 3.7%; cocaine: 5.6% versus 1.4%; solvents: 3.9% versus 0.9%; 
and crack: 8.8% versus 2.2%, respectively). Menezes et al.18 found similar results, in which 
men with SMI were 2.7 times more likely than women to have problems related to drug use. 
In Brazil, a household survey on drug use also indicated that men had a higher prevalence of 
use (lifetime) than women (marijuana: 14.3% versus 5.1%; cocaine: 5.4% versus 1.2%; solvents: 
10.3% versus 3.3%, respectively)1. 
We found that recent illicit drug use has strong and significant associations with alcohol and 
tobacco use for both men and women. Hasin et al.10 point out the consistency of associations 
between drug abuse, nicotine dependence, and alcohol use disorders even when controlling 
for sociodemographic characteristics and other comorbidities. De Leon et al.15 indicate that 
these overlapping disorders have important implications for treatment as patients with SMI 
who also abuse both alcohol and drugs rarely stop abusing just one of them. 
The sociodemographic characteristics associated with drug use among patients with mental 
illnesses in our study are similar to those found in the general population. Our results are 
corroborated by previous studies that also indicate higher prevalence among men, younger 
persons18, and those with lower schooling2,11. Lower schooling was associated with recent use 
among men only, and professing a religion was negatively associated among women only. 
Professing a religion leads to the adoption of values and behavioral changes that restrict the 
use of illicit substances, thus acting as a protective factor24. 
Studies have shown that patients with mental illnesses are sexually active and present high 
rates of sexual risk behavior9,17,31. In our study, we observed that recent illicit drug use was 
associated with younger age at sexual debut and having two or more sexual partners. The 
use of drugs may increase sexual risk behavior by modifying sexual impulses, thus increasing 
sexual desire, disinhibiting sexual behavior, or interfering with the practice of safer sex, or all 
of these27. 
Illicit drug use was independently associated with a history of incarceration for both genders 
and with homelessness and physical violence for men. A British survey showed that 16% to 
42% of the incarcerated population with psychosis presented dependence on some drug in 
the year prior to incarceration4. Persons with mental illness are more exposed to physical 
violence than the general population, which in turn is associated with illicit drug use, 
unstable housing or homelessness21, and a history of incarceration16,21. There is evidence that 
persons with mental illness are most often victims rather than perpetrators of violence21. 
However, some authors have suggested an increase in violent behaviors when illicit drug use 
is present2. These associations suggest the need to introduce new policies to address drug use 
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and the need to prevent violence in mental health programs. We should note the existence 
of an important initiative in Brazil, named “doctor’s office in the street” (Consultório de Rua, 
in Portuguese), which provides mobile health units for the health care of the homeless and 
it attempts to link them to health care units for continuous follow-upa. 
The association between current psychiatric hospitalization and illicit drug use in the past year 
found in our study is of clinical and management relevance. First, this finding corroborates 
the evidence that the association between mental disorders and drug use may lead to results 
of great severity2. Furthermore, according to the studies of Kessler13, a history of previous 
psychiatric hospitalization may indicate higher chances of developing future substance use 
disorders. The temporal relationship between the emergence of psychiatric and substance use 
disorders is widely discussed in the literature. Kessler et al.14 and Swendsen et al.28 indicate 
that the emergence of a psychiatric disorder typically precedes substance use disorder. 
However, in a literature review of studies with patients with schizophrenia, Gregg et al.7 
reported no clear consensus regarding this matter. 
This study is the first one to assess illicit drug use in a representative sample of psychiatric 
patients under care in public mental health services in Brazil. However, some limitations 
must be pointed out. The results presented here may not be generalized to all psychiatric 
patients because of the exclusion of more severely ill patients who were unable to participate. 
We did not directly assess psychiatric diagnoses or symptoms, but we rather obtained these 
data from medical charts. Patients who were treated exclusively at substance use centers 
(CAPS AD) were excluded, which might have led to the underestimation of the prevalence 
of illicit drug use among persons with mental illnesses. Despite the odds ratio being an 
appropriate measure for this study, it can potentially overestimate associations. In addition, 
the cross-sectional design of the study limits our capacity to establish a direct cause and 
effect and additional studies are necessary. 
Our results have important implications for the psychiatric care in Brazil. The treatment 
of psychiatric patients who use illicit drugs is a major challenge for mental health services. 
Often professionals are not prepared to assist these persons, and services are not structured 
to provide high quality treatment or referral. There is a need for comprehensive integrated 
services to assist this vulnerable population. Strategies should be gender specific with a 
particular emphasis on the vulnerability to illicit drug use of men with mental illness. 
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